Pressroom

Trending Topics

 

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator

Memorial Sloan Kettering experts are available to comment on the exciting new research presented at the 2015 American Association of Cancer Research annual meeting, including research in immunotherapy in pediatric cancers and melanoma, breast cancer, and many others. For more information and to set up interviews or access photos and video, email Rebecca Williams at williamr@mskcc.org.
Saturday, April 18, 2015
 
Memorial Sloan Kettering breast cancer experts are available to comment on breaking news out of this year’s annual meeting set to take place December 9 through 13.
Monday, December 8, 2014
 
The largest hematology-oncology meeting in the world will take place in San Francisco from December 6 through 9. Memorial Sloan Kettering experts are available to comment on breaking news out of the meeting.
Tuesday, December 2, 2014
 
See all trending topics
 

Press Releases

 
Memorial Sloan Kettering Cancer Center introduced a new, consumer-friendly web presence for www.mskcc.org (Memorial Sloan Kettering Cancer Center) and www.sloankettering.edu (Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center), featuring an innovative platform and on-demand navigation for patients, caregivers, researchers, healthcare professionals, and graduate students, among other core audiences.
Tuesday, May 5, 2015
 
Positive results from a clinical trial published in The New England Journal of Medicine show that the combination of the immunotherapy drugs ipilimumab (Yervoy) and nivolumab (Opdivo), produced significantly better outcomes than ipilimumab alone in patients with advanced melanoma. A second piece in the same issue from MSK details a dramatic response occurring after a single dose of the combination therapy.
Monday, April 20, 2015
 
Researchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.
Thursday, April 9, 2015
 
See all press releases
 

On Our Blog

 
ANNOUNCEMENT
This week marked the launch of the redesigned MSKCC.org. Optimized for smartphone and tablet, the new site is focused on one thing: you.
Wednesday, May 6, 2015
 
Q&A
Memorial Sloan Kettering plastic surgeon Peter Cordeiro describes breast reconstruction options for women undergoing mastectomy.
Tuesday, May 5, 2015
 
ASK THE EXPERT
Learn about multigene panel testing and some of its potential pros and cons from one of our experts.
Thursday, April 23, 2015
 
See all blog posts
 
 

For Journalists

For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.
 
After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to the News@MSKCC newsletter

Our email newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign up

Unsubscribe »